CD8A and COVID-19: Thevarajan et al. found rapid production and significant increase in activated CD8+ T cells in young COVID‐19 patients with good prognosis on day 7–9 after SARS‐CoV‐2 infection,46 while the number of CD4+ and CD8+ T cells was significantly reduced in elderly and critically ill patients.47